Semaglutide, the GLP-1 receptor agonist, is an FDA-approved injectable treatment for chronic weight loss programs. Semaglutide may also go by other names, including Ozempic, Rybelsus, and Wegovy. The drug functions by boosting the body’s natural insulin secretion, resulting in appetite suppression and weight loss. Scientific research has shown Semaglutide’s impressive effectiveness across multiple studies.
Semaglutide is an injectable drug that mimics the function of the glucagon-like peptide-1 (GLP-1) hormone, which regulates appetite within the brain. The process suppresses appetite and results in other benefits, such as reduced blood sugar by limiting sugar production in the liver, which can prove helpful for pre-diabetics and individuals with type-2 diabetes.
Semaglutide treatment provides multiple benefits that can significantly enhance active weight loss programs. These positive long-term effects include:
The common side effects of Semaglutide include nausea, vomiting, constipation, and diarrhea. However, healthcare practitioners may effectively control these symptoms early in the treatment. Gradually, Semaglutide’s potential side effects may diminish as your body grows accustomed to it.
Individuals suffering from pre-existing health conditions such as pancreatitis, decreased kidney function, low blood sugar, multiple endocrine neoplasia type 2, gallbladder disease, and diabetic retinopathy should avoid Semaglutide treatment. Speak with your specialized weight-loss consultant for a comprehensive list of conditions that require caution.
Virtually any adult who wants to enhance their appearance can be a good candidate for lip fillers. However, patients should ensure that they truly want to modify their appearance – rather than meet someone else’s ideal. It is also essential for patients to have realistic expectations about the outcome.
While lip fillers may enhance one’s lips, they will not dramatically alter one’s overall appearance. The ideal candidate for lip fillers should also be a nonsmoker in good health. Those with an active infection (such as oral herpes), blood-clotting problems, diabetes, and lupus may not be suitable candidates for lip fillers. Patients should also let their injector know if they have had cold sores in the past, have any known allergies, or are allergic to lidocaine.
PDO thread lifts require minimal recovery time, with some swelling and bruising for the first 24 to 48 hours. Most patients can return to most of their daily routines right away. To avoid accidentally dislodging the thread, patients should refrain from rubbing or touching their face as much as possible the week after the procedure.
Patients may also be advised to avoid pursing their lips, drinking through a straw, or smoking for the first several weeks. They may also want to avoid saunas, intense exercise, and sleeping on their side for the first one to two weeks. We advise sleeping with the head propped up on a pillow to avoid accidentally rolling onto the face in the middle of the night.
Aside from drug contraindications and the existing health conditions listed above, Semaglutide works well for patients with varying BMI, age, and ethnicity.
You will need to schedule an initial appointment with a qualified weight loss professional to assess your health history and FDA recommendations for obesity treatment to determine your suitability for the program. Upon approval, your weight loss professional will arrange to start Semaglutide treatment with a low dosage, gradually rising to around 2.4mg per week.
Your weight loss expert administers the drug by injection once weekly under the skin of the thigh, upper arm, or abdomen, with or without meals.
Weight loss experts may prescribe Semaglutide treatment and other ongoing initiatives, such as personalized exercise plans, behavioral intervention, and lipotropic injections to improve metabolism. Research studies have shown that participants prescribed 2.4mg of Semaglutide once a week who adhere to a healthy lifestyle demonstrate a sustained and significant reduction in body weight.
Semaglutide is usually started at 0.25 mg weekly and is increased by 0.25 mg every four weeks until reaching the target or tolerated dose. In addition to weight loss results, studies show improved quality of life for 40% to 50% of participants.
Scientific findings have also shown that some Semaglutide users had regained their lost weight upon discontinuing treatment.
